[HTML][HTML] Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known?
NM Dixit, A Churchill, A Nsair, JJ Hsu - American heart journal plus …, 2021 - Elsevier
Abstract Post-Acute COVID-19 Syndrome (PACS) is defined by persistent symptoms> 3–4
weeks after onset of COVID-19. The mechanism of these persistent symptoms is distinct from …
weeks after onset of COVID-19. The mechanism of these persistent symptoms is distinct from …
[HTML][HTML] Prognostic performance of troponin in COVID-19: A diagnostic meta-analysis and meta-regression
Background Cardiac injury is frequently encountered in patients with coronavirus disease
2019 (COVID-19) and is associated with increased risk of mortality. Elevated troponin may …
2019 (COVID-19) and is associated with increased risk of mortality. Elevated troponin may …
Elevated plasma fibrinogen is associated with excessive inflammation and disease severity in COVID-19 patients
J Sui, DF Noubouossie, S Gandotra… - Frontiers in cellular and …, 2021 - frontiersin.org
Background The coronavirus disease-19 (COVID-19) is characterized with intense
inflammatory response, cardiac involvement, and coagulopathy. Fibrinogen, as a biomarker …
inflammatory response, cardiac involvement, and coagulopathy. Fibrinogen, as a biomarker …
The impact of COVID-19 and COVID vaccination on cardiovascular outcomes
COVID-19 is an independent risk factor for cardiovascular disease. COVID-19 vaccination
may prevent this, but in some cases, COVID-19 vaccination may cause myocarditis or …
may prevent this, but in some cases, COVID-19 vaccination may cause myocarditis or …
Serum troponin, D‐dimer, and CRP level in severe coronavirus (COVID‐19) patients
Background Abnormal inflammation coagulation biomarker levels of troponin, C‐reactive
protein (CRP), and D‐dimer levels in serum have been demonstrated to be associated and …
protein (CRP), and D‐dimer levels in serum have been demonstrated to be associated and …
Circulating calprotectin as a biomarker of COVID-19 severity
M Mahler, PL Meroni, M Infantino… - Expert review of …, 2021 - Taylor & Francis
ABSTRACT Introduction Coronavirus disease 2019 (COVID-19) is an infectious disease
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …
Cardiac troponin and COVID‐19 severity: results from BIOCOVID study
L García de Guadiana‐Romualdo… - European journal of …, 2021 - Wiley Online Library
Background Myocardial injury is a common finding in COVID‐19 strongly associated with
severity. We analysed the prevalence and prognostic utility of myocardial injury …
severity. We analysed the prevalence and prognostic utility of myocardial injury …
Prevalence and prognostic value of elevated troponins in patients hospitalised for coronavirus disease 2019: a systematic review and meta-analysis
Background The clinical significance of cardiac troponin measurement in patients
hospitalised for coronavirus disease 2019 (covid-19) is uncertain. We investigated the …
hospitalised for coronavirus disease 2019 (covid-19) is uncertain. We investigated the …
Cardiac biomarkers and detection methods for myocardial infarction
Background A significant heart attack known as a myocardial infarction (MI) occurs when the
blood supply to the heart is suddenly interrupted, harming the heart muscles due to a lack of …
blood supply to the heart is suddenly interrupted, harming the heart muscles due to a lack of …
[HTML][HTML] Proteome-wide Mendelian randomization identifies causal links between blood proteins and severe COVID-19
In November 2021, the COVID-19 pandemic death toll surpassed five million individuals. We
applied Mendelian randomization including> 3,000 blood proteins as exposures to identify …
applied Mendelian randomization including> 3,000 blood proteins as exposures to identify …